UPC 財務： Universe Pharmaceuticals Inc AI 分析

首頁

股票

UPC

財務狀況

UPC 財務

Universe Pharmaceuticals Inc

$2.34

4.12%

$0.09

收盤價：Mar 26, 16:00:00 GMT-4

$2.54

8.54%

$0.2

盤後：Mar 26, 20:00:00 GMT-4

概觀預測收益股利財務狀況

關鍵數據

前收市價

$2.24

開盤價

$2.24

當日範圍

$2.24 - $2.54

52週區間

$2 - $11

交易量

3.9K

平均成交量

75.6K

股息收益率

每股盈餘 (TTM)

-10.13

市值

$1.4M

什麼是 UPC？

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.

功能特性

資源

市場

收入

資產負債表

現金流量

年度

每季

UPC 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	09/30/2025	09/30/2024	09/30/2023	09/30/2022	09/30/2021
營收	17	17	23	32	40	47
營收年增率 (YoY)	-26%	-26%	-28%	-20%	-15%	56.99%
營收成本	11	11	16	21	18	22
毛利	6	6	6	10	21	25
銷售、一般及管理費用	8	8	10	9	21	6
研發	0	0	2	4	7	5
營業費用	9	9	14	14	29	11
其他非營業收入 (費用)	0	0	0	0	0	0
稅前淨利	-3	-3	-8	-4	-7	13
所得稅費用	0	0	0	2	0	2
淨利	-3	-3	-8	-6	-8	11
淨利成長	-63%	-63%	33%	-25%	-173%	56.99%
稀釋後流通股數	0.56	0.45	0.01	0	0	0.21
股數年變動 (YoY)	2,487%	3,180%	132%	0%	-97%	-10%
每股盈餘 (稀釋)	-6.51	-8.05	-626.96	-1,089.57	-1,447.01	53.67
每股盈餘成長率	-98%	-99%	-42%	-25%	-2,796%	66%
自由現金流	-5	-5	-9	1	-1	-2
每股自由現金流	--	--	--	--	--	--
毛利率	35.29%	35.29%	26.08%	31.25%	52.5%	53.19%
營業利益率	-11.76%	-11.76%	-34.78%	-9.37%	-17.5%	27.65%
淨利率	-17.64%	-17.64%	-34.78%	-18.75%	-20%	23.4%
自由現金流利潤率	-29.41%	-29.41%	-39.13%	3.12%	-2.5%	-4.25%
EBITDA	-2	-2	-8	-3	-7	13
EBITDA 利潤率	-11.76%	-11.76%	-34.78%	-9.37%	-17.5%	27.65%
EBITDA 中的折舊與攤銷	0	0	0	0	0	0
EBIT	-2	-2	-8	-3	-7	13
EBIT 利潤率	-11.76%	-11.76%	-34.78%	-9.37%	-17.5%	27.65%
有效稅率	0%	0%	0%	-50%	0%	15.38%

Follow-Up Questions

Universe Pharmaceuticals Inc 的關鍵財務報表是什麼？



根據最新的財務報表（Form-10K），Universe Pharmaceuticals Inc 的總資產為 $69，淨isProfitable}為 $-3

UPC 的關鍵財務比率是什麼？



Universe Pharmaceuticals Inc 的流動比率為 5.3，淨利潤率為 -17.64，每股銷售為 $37.28。

Universe Pharmaceuticals Inc 的收入按細分市場或地理位置如何劃分？



Universe Pharmaceuticals Inc 最大收入來源為 Traditional Chinese Medicine Derivatives，在最近的收益報告中收入為 32,308,735。就地區而言，China 是 Universe Pharmaceuticals Inc 的主要市場，收入為 32,308,735。

Universe Pharmaceuticals Inc 是否盈利？



無，根據最新的財務報表，Universe Pharmaceuticals Inc 的淨損失為 $-3

Universe Pharmaceuticals Inc 有負債嗎？



是的，Universe Pharmaceuticals Inc 的負債為 13

Universe Pharmaceuticals Inc 的流通股有多少？



Universe Pharmaceuticals Inc 的總流通股為 0.56

Universe Pharmaceuticals Inc (UPC) 財務

UPC 股價走勢圖